Form 8-K

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 16, 2007

BAUSCH & LOMB INCORPORATED

(Exact name of registrant as specified in its charter)

New York	1-4105	16-0345235
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

One Bausch & Lomb Place, Rochester, NY		14604-2701
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (585) 338.6000

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

ITEM 5.02

DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS.

On February 19, 2007, the Company announced that the Board of Directors (the “Board”) elected Catherine M. Burzik to the Board. Ms. Burzik will serve until the next annual meeting of shareholders, when she will be nominated for re-election.

Ms. Burzik was identified as a Board candidate by a third party search firm, Russell Reynolds Associates, engaged by the Board’s Nominating and Governance Committee. At this time, Ms. Burzik has not been appointed to a Board committee.

Ms. Burzik’s biography is contained in the Company’s press release, a copy of which is attached hereto as Exhibit 99.1.

ITEM 9.01	FINANCIAL STATEMENTS AND EXHIBITS.
(a)	Financial statements of businesses acquired. Not applicable
(b)	Pro forma financial information. Not applicable
(c)	Exhibits. The following exhibit is filed herewith: 99.1 Press Release, dated February 19, 2007.

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

BAUSCH & LOMB INCORPORATED


/s/ Robert B. Stiles
Robert B. Stiles
Senior Vice President and General Counsel

Date: February 20, 2007

News

Bausch & Lomb Adds Catherine M. Burzik to Board of Directors

FOR RELEASE MONDAY, FEBRUARY 19, 2007

ROCHESTER, NEW YORK - Bausch & Lomb (NYSE/BOL) announced that Catherine M. Burzik, president and chief executive officer of Kinetic Concepts, Inc. (NYSE/KCI) has been elected to its Board of Directors. Ms. Burzik will serve until the next annual meeting of shareholders, when she will be nominated for election to a one-year term by shareholders.

“Cathy Burzik brings to the Bausch & Lomb board a wealth of experience in the management of global medical technology businesses,” said Ronald L. Zarrella, chairman and CEO of the company. “Such expertise and perspective will be invaluable as we continue to invest in and develop new healthcare technologies that can drive future growth.”

Ms. Burzik joined KCI, a $1.4 billion company headquartered in San Antonio, Texas that develops and markets advanced therapeutic systems designed to improve wound healing and reduce pulmonary and circulatory complications associated with patient immobility, in November 2006.

Before joining KCI, Ms. Burzik served as president of Applied Biosystems, a unit of Applera Corporation. She has also held senior positions at Eastman Kodak and Johnson & Johnson. At Eastman Kodak, her executive positions included CEO and President of Kodak Health Imaging Systems and general manager/vice president of Corporate Marketing. She served on the board of directors at Cordis Corporation, prior to its acquisition by J&J. At J&J she ran the Critikon medical technology business and subsequently was appointed president of J&J’s Ortho-Clinical Diagnostics, Inc. unit.

Ms. Burzik, 56, has a BA in mathematics from Canisius College in Buffalo, New York, and a MA in Mathematics from the University of Buffalo. She has also attended executive management programs at Penn State, Northwestern University’s Kellogg School of Management and the Center for Creative Leadership. She serves on the board of trustees of Canisius College.

###

Media Contact: Investor Relations Contact:

Barbara Kelley Dan Ritz

585.338.5386 585.338.5802

bkelley@bausch.com dritz@bausch.com

_____________________________________

Bausch & Lomb is the eye health company, dedicated to perfecting vision and enhancing life for consumers around the world. Its core businesses include soft and rigid gas permeable contact lenses and lens care products, and ophthalmic surgical and pharmaceutical products. The Bausch & Lomb name is one of the best known and most respected healthcare brands in the world. Founded in 1853, the Company is headquartered in Rochester, New York. Bausch & Lomb employs approximately 13,700 people worldwide and its products are available in more than 100 countries. More information about the Company is on the Bausch & Lomb Web site at www.bausch.com. Copyright Bausch & Lomb Incorporated.